Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential22Abbreviations: ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; Cy, Cyanine; DLCL, diffuse large cell lymphoma; dNTPs, deoxyribonucleotides; ESTs, expressed sequence tags; mRNA, messenger RNA; NHL, non-Hodgkin’s lymphoma; ORF, open reading frame; RT-PCR, reverse transcription-polymerase chain reaction; and 17AAG, 17-allylamino,17-demethoxygeldanamycin.
- 1 December 2001
- journal article
- review article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 62 (10), 1311-1336
- https://doi.org/10.1016/s0006-2952(01)00785-7
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistanceOncogene, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arraysOncogene, 2000
- A gene expression database for the molecular pharmacology of cancerNature Genetics, 2000
- Systematic variation in gene expression patterns in human cancer cell linesNature Genetics, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- The Hallmarks of CancerCell, 2000
- Molecular interactions on microarraysNature Genetics, 1999
- Drug target validation and identification of secondary drug target effects using DNA microarraysNature Medicine, 1998
- dbEST — database for “expressed sequence tags”Nature Genetics, 1993